{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:10Z","timestamp":1787070910874,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Although concurrent chemoradiotherapy is the standard of care for inoperable locally advanced head and neck cancer, induction chemotherapy is considered an alternative approach by head and neck oncologists worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To evaluate the response to induction chemotherapy in terms of loco-regional control and treatment-related toxicity in inoperable locally advanced head and neck cancer patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This prospective study was conducted on patients who received two to three cycles of induction chemotherapy. Following this, response assessment was performed clinically. Grading of radiation-induced oral mucositis and any interruptions in treatment were noted. At 8 weeks following treatment, magnetic resonance imaging-based radiological response assessment was performed using RECIST criteria version 1.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our data revealed 57.7% complete response rate with induction chemotherapy, followed by chemoradiation therapy. We observed that post induction, 67.5% and 47.5% patients had reduction in T-stage (&lt;0.001) and N-stage of disease (&lt;0.001), respectively, with complete response more achieved in younger patients (\u226450 years). Chemotherapy-induced bone marrow suppression and febrile neutropenia occurred in 7.5% patients. We demonstrated that a higher grade of radiation-induced mucositis was noticed among those receiving three cycles of induction chemotherapy (ICT) and aged &gt;50 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We conclude that induction chemotherapy could still be a viable option for down-staging unresectable locally advanced disease, especially for younger patients in terms of better treatment response and tolerability. The number of cycles of ICT seems to influence radiation-induced mucositis. This study underscores the need for further studies to determine the exact role of ICT in locally advanced head and neck cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_839_22","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T01:20:32Z","timestamp":1686619232000},"page":"420-425","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Induction chemotherapy in head and neck cancer \u2013 Boon or bane?"],"prefix":"10.4103","volume":"19","author":[{"given":"Aprajita","family":"Mall","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Christian Medical College and Hospital, Ludhiana, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preety","family":"Negi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Christian Medical College and Hospital, Ludhiana, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin Oommen","family":"Philip","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Christian Medical College and Hospital, Ludhiana, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela A.","family":"Kingsley","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Christian Medical College and Hospital, Ludhiana, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0019-509X.278971","article-title":"Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck","volume":"57","author":"Kumar","year":"2020","journal-title":"Indian J Cancer"},{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC):An update on 93 randomized trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","article-title":"Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck:Role, controversy, and future directions","volume":"29","author":"Haddad","year":"2018","journal-title":"Ann Oncol"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/annonc\/mdq185","article-title":"Squamous cell carcinoma of the head and neck:EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Gregoire","year":"2010","journal-title":"Ann Oncol"},{"key":"R5-20241021","first-page":"3","article-title":"The changing landscape of induction chemotherapy in head and neck cancers","volume":"5","author":"Negi","year":"2019","journal-title":"Int J Health Res Medico Leg Prac"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2007.06.015","article-title":"Neoadjuvant chemotherapy in head and neck cancer:Should it be revisited?","volume":"256","author":"Specenier","year":"2007","journal-title":"Cancer Lett"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hed.23891","article-title":"Effect of induction chemotherapy on survival in locally advanced head and neck carcinoma treated with concurrent chemoradiotherapy:Single center experience","volume":"38","author":"Ock","year":"2016","journal-title":"Head Neck"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/fon-2016-0073","article-title":"Induction chemotherapy for head and neck cancer:Is there still a role?","volume":"12","author":"Ove","year":"2016","journal-title":"Future Oncol"},{"key":"R9-20241021","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","article-title":"Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers:An individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group","volume":"31","author":"Blanchard","year":"2013","journal-title":"J Clin Oncol"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2013.54.6309","article-title":"Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer","volume":"32","author":"Cohen","year":"2014","journal-title":"J Clin Oncol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(13)70011-1","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM):A randomized phase 3 trial","volume":"14","author":"Haddad","year":"2013","journal-title":"Lancet Oncol"},{"key":"R14-20241021","first-page":"1","article-title":"The slippery role of induction chemotherapy in head and neck cancer:Myth and reality","volume":"23","author":"Ferrari","year":"2020","journal-title":"Front Oncol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.2010-S3-03","article-title":"Induction chemotherapy for head and neck cancer:Recent data","volume":"15","author":"Vokes","year":"2010","journal-title":"Oncologist"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/djh306","article-title":"Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer:10-year follow-up","volume":"96","author":"Zorat","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R17-20241021","article-title":"Induction chemotherapy for locoregionally advanced head and neck cancer. A concept with continuing promise. Educational book, Chicago, Illinois","author":"Vokes","year":"2003","journal-title":"American Society of Clinical Oncology Annual Meeting"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4172\/2161-119X.1000108","article-title":"Induction chemotherapy followed by concomitant chemoradiation in head and neck squamous cell carcinoma:A single institution experience","volume":"2","author":"Delouya","year":"2012","journal-title":"Otolaryngol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdx299","article-title":"Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II \u2013III trial","volume":"28","author":"Ghi","year":"2017","journal-title":"Ann Oncol"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/ccij.ccij_42_18","article-title":"Role of induction chemotherapy in downstaging of locally advanced head and neck squamous cell cancer","volume":"7","author":"Ahirwar","year":"2018","journal-title":"Clin Cancer Investig J"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.amjoto.2017.04.004","article-title":"Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy","volume":"38","author":"Shah","year":"2017","journal-title":"Am J Otolaryngol"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"412","DOI":"10.12788\/jcso.0292","article-title":"Toxicity analysis of docetaxel, cisplatin, and 5-fluorouracil neoadjuvant chemotherapy in Indian patients with head and neck cancers","volume":"14","author":"Patil","year":"2016","journal-title":"J Com Supp Oncol"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/0019-509X.175601","article-title":"A prospective study to assess the efficacy and toxicity of 5-fluorouracil and cisplatin versus taxane and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell cancer in a regional cancer center in India","volume":"52","author":"Lakshmaiah","year":"2015","journal-title":"Indian J Cancer"},{"key":"R24-20241021","first-page":"10","article-title":"Oral mucositis:Update on prevention and management strategies","volume":"34","author":"Erowele","year":"2009","journal-title":"US Pharm"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_839_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:46Z","timestamp":1787067526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_839_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_839_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2022-04-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}